Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02671617
Other study ID # eHIITCa
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date August 2016
Est. completion date August 2018

Study information

Verified date September 2018
Source University of Nottingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomized control trial will determine the effect of short term high intensity interval training (HIIT) on physical fitness, in an elderly patient group with active cancer, prior to surgical resection.

Half of the recruited patients will act as a control group and the other half will undergo a HIIT protocol.


Description:

High intensity interval training (HIIT) has been shown to achieve similar and in some studies better improvements in aerobic fitness versus more traditional endurance based exercise over the same time period. HIIT has also been shown to produce these improvements over a shorter timescale than other methods, in the region of 2-6 weeks. One widely reported barrier to exercise is time availability, HIIT training may be a favorable option to increase fitness as the total time spent exercising is significantly less than other methods. HIIT induces improvements in cardiovascular parameters in healthy elderly subjects, investigators aim to investigate whether these improvements can be matched in patients with cancer and further elucidate the mechanisms behind improvements seen with this type of training.


Recruitment information / eligibility

Status Completed
Enrollment 40
Est. completion date August 2018
Est. primary completion date July 2018
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria:

- Aged over 65 years (no upper age limit).

- Histologically proven, radiologically or direct visualisation leading to high clinical suspicion of cancer.

- Sufficient mobility to be able to exercise on a static exercise bike.

- Ability to give informed consent.

- Ability to travel to RDH to complete the HIIT sessions (may also rely upon dependents/relatives to provide transport).

Exclusion Criteria:

- Adjuvant systemic chemotherapy / radiotherapy treatment for this cancer. Participants with a significant past medical history of:

- Myocardial infarction (within last 6 months)

- Unstable Angina

- Heart failure (NYHA class III/IV)

- Uncontrolled Hypertension (BP>160/100)

- Previous stroke/TIA

- Severe respiratory disease inc. known pulmonary hypertension(>25 mmHg), Forced Expiratory Volume in 1 second <1.5l.

- Brittle asthma / exercise induced asthma

- Known cerebral aneurysm.

- Inclusion in a recent (within 3 months) study which included any form of exercise, taking a drug or ionising radiation.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
High intensity interval training (HIIT)
Preoperative HIIT protocol.

Locations

Country Name City State
United Kingdom Royal Derby Hospital Derby Derbyshire

Sponsors (1)

Lead Sponsor Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary VO2AT (VO2 at anaerobic threshold) Change in anaerobic threshold seen during maximal exercise test (pre and post intervention). Baseline and 4 weeks
Secondary VO2peak Change in peak volume of oxygen consumption during maximal exercise test (pre and post intervention). Baseline and 4 weeks
Secondary Subjective acceptability of HIIT preoperatively (via questionnaire) Assessment of whether our HIIT protocol is acceptable to patients in this age group. After 4 weeks of HIIT.
Secondary Muscle protein synthesis rate changes with HIIT. Assessment of the effect HIIT has on rate of muscle protein synthesis in this group. Baseline and 4 weeks.
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients